SCHEMBL31613833

SCHEMBL31613833

CC(C)(C)OC(=O)Nc1cccc2c1nc1n2CCC1(F)F

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ RXFP1 Q9HBX9 1/20 0.36
▸ BRD4 O60885 3/20 0.36
▸ P2RX7 Q99572 1/20 0.36
▸ BRD9 Q9H8M2 1/20 0.35
▸ OPRM1 P35372 1/20 0.35
▸ OPRD1 P41143 1/20 0.35
▸ OGFRL1 Q5TC84 1/20 0.35
▸ GSK3B P49841 1/20 0.35
▸ DYRK1A Q13627 1/20 0.35
▸ METAP1 P53582 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ FSHR P23945 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ IDO1 P14902 1/20 0.33
▸ PARP1 P09874 1/20 0.33
▸ SYK P43405 1/20 0.33
▸ LCK P06239 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31047350 0.77 TSHR (0.37) RXFP1BRD4P2RX7BRD9OPRM1
SCHEMBL31047351 0.77 TSHR (0.37) RXFP1BRD4P2RX7BRD9OPRM1
SCHEMBL31613842 0.77 OPRM1 (0.39) RXFP1BRD4P2RX7BRD9OPRM1
SCHEMBL31613824 0.76 POLB (0.40) BRD4BRD9OPRM1OPRD1OGFRL1
SCHEMBL30842140 0.75 POLB (0.42) OPRM1OPRD1OGFRL1LMNAPOLB
SCHEMBL30842143 0.74 OPRM1 (0.40) RXFP1BRD4P2RX7BRD9OPRM1
SCHEMBL31047343 0.72 OPRM1 (0.43) RXFP1BRD4BRD9OPRM1OPRD1
SCHEMBL30842149 0.71 KIF18A (0.49) —
SCHEMBL31037927 0.69 GRM2 (0.33) —
SCHEMBL31037911 0.69 PIK3CB (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4567032-A1 KIF18A INHIBITOR COMPOUND, AND PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD THEREFOR AND USE THEREOF Changchun Genescience Pharmaceutical Co., Ltd. (CN) 2025-06-11 — — EP disclosed
Send feedback